| 臺大學術典藏 |
2020-06-17T05:21:30Z |
Interaction of the G182C polymorphism in the APOA5 gene and fasting plasma glucose on plasma triglycerides in Type 2 diabetic subjects
|
YI-DER JIANG;Chuang L.-M.;Chiu K.C.;Lee K.-C.;Kuo S.-S.;Chou W.-L.;Yen C.-J.; YI-DER JIANG; Yen C.-J.; Chou W.-L.; Kuo S.-S.; Lee K.-C.; Chiu K.C.; Chuang L.-M. |
| 臺大學術典藏 |
2020-06-01T06:57:14Z |
Immediate knowledge improvement and long-term teaching confidence after general medicine faculty training program
|
Tseng F.-Y.;Lin L.-C.;Ko B.-S.;Chu T.-S.;Tsai S.-L.;Sheng W.-H.;Yen C.-J.;Chang C.-H.;Wu C.-H.;Shyang-Rong Shih;Chiu W.-Y.;Pan S.-C.;Chen W.-P.;Chang P.-Y.; Tseng F.-Y.; Lin L.-C.; Ko B.-S.; Chu T.-S.; Tsai S.-L.; Sheng W.-H.; Yen C.-J.; Chang C.-H.; Wu C.-H.; SHYANG-RONG SHIH; Chiu W.-Y.; Pan S.-C.; Chen W.-P.; Chang P.-Y. |
| 臺大學術典藏 |
2020-06-01T04:30:51Z |
Interaction of the G182C polymorphism in the APOA5 gene and fasting plasma glucose on plasma triglycerides in Type 2 diabetic subjects
|
LEE-MING CHUANG;Chiu K.C.;Lee K.-C.;Kuo S.-S.;Chou W.-L.;Yen C.-J.;Jiang Y.-D.; Jiang Y.-D.; Yen C.-J.; Chou W.-L.; Kuo S.-S.; Lee K.-C.; Chiu K.C.; LEE-MING CHUANG |
| 臺大學術典藏 |
2020-06-01T03:55:31Z |
Immediate knowledge improvement and long-term teaching confidence after general medicine faculty training program
|
Fen-Yu Tseng;Lin L.-C.;Ko B.-S.;Chu T.-S.;Tsai S.-L.;Sheng W.-H.;Yen C.-J.;Chang C.-H.;Wu C.-H.;Shih S.-R.;Chiu W.-Y.;Pan S.-C.;Chen W.-P.;Chang P.-Y.; FEN-YU TSENG; Lin L.-C.; Ko B.-S.; Chu T.-S.; Tsai S.-L.; Sheng W.-H.; Yen C.-J.; Chang C.-H.; Wu C.-H.; Shih S.-R.; Chiu W.-Y.; Pan S.-C.; Chen W.-P.; Chang P.-Y. |
| 臺大學術典藏 |
2020-05-26T09:26:57Z |
A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Lin C.-C;Su W.-C;Yen C.-J;Hsu C.-H;Su W.-P;Yeh K.-H;Lu Y.-S;Cheng A.-L;Huang D.C.-L;Fritsch H;Voss F;Taube T;Chih-Hsin Yang; Lin C.-C; Su W.-C; Yen C.-J; Hsu C.-H; Su W.-P; Yeh K.-H; Lu Y.-S; Cheng A.-L; Huang D.C.-L; Fritsch H; Voss F; Taube T; CHIH-HSIN YANG |
| 臺大學術典藏 |
2020-05-26T03:25:53Z |
Old age is a positive modifier of renal outcome in Taiwanese patients with stages 3–5 chronic kidney disease
|
Yu-Hsiang Chou;Yen C.-J.;Lai T.-S.;Chen Y.-M.; YU-HSIANG CHOU; Yen C.-J.; Lai T.-S.; Chen Y.-M. |
| 臺大學術典藏 |
2020-05-25T07:35:22Z |
A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Chia-Chi Lin; Su W.-C; Yen C.-J; Hsu C.-H; Su W.-P; Yeh K.-H; Lu Y.-S; Cheng A.-L; Huang D.C.-L; Fritsch H; Voss F; Taube T; Yang J.C.-H. |
| 臺大學術典藏 |
2020-05-25T07:35:00Z |
Phase I Dose-Escalation and -Expansion Study of Telisotuzumab (ABT-700), an Anti-c-Met Antibody, in Patients with Advanced Solid Tumors
|
Ansell P; Motwani M; Wong S; Yue H; Wang L; Reilly E; Afar D; Naumovski L; Ramanathan R.K.; Strickler J.H; LoRusso P; Salgia R; Kang Y.-K; Yen C.J; Chia-Chi Lin |
| 臺大學術典藏 |
2020-05-25T07:35:00Z |
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours
|
Bogenrieder T; Twelves C; Cheng A.-L.; Huang D.C.-L; Strelkowa N; Goeldner R.-G; Schmid U; Fuertig R; Buschke S; Jove M; Anthoney A; Yen C.-J; de Bono J; Chia-Chi Lin; Chen L.-T; Corral J; Michalarea V; Rihawi K; Ong M; Lee J.-H; Hsu C.-H; Yang J.C.-H; Shiah H.-S |
| 臺大學術典藏 |
2020-05-25T06:51:54Z |
A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Lin C.-C;Su W.-C;Yen C.-J;Hsu C.-H;Su W.-P;Yeh K.-H;Yen-Shen Lu;Cheng A.-L;Huang D.C.-L;Fritsch H;Voss F;Taube T;Yang J.C.-H.; Lin C.-C; Su W.-C; Yen C.-J; Hsu C.-H; Su W.-P; Yeh K.-H; YEN-SHEN LU; Cheng A.-L; Huang D.C.-L; Fritsch H; Voss F; Taube T; Yang J.C.-H. |
| 臺大學術典藏 |
2020-04-28T07:25:19Z |
A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Lin C.-C.;Su W.-C.;Yen C.-J.;Chih-Hung Hsu;Su W.-P.;Yeh K.-H.;Lu Y.-S.;Cheng A.-L.;Huang D.C.-L.;Fritsch H.;Voss F.;Taube T.;Yang J.C.-H.; Lin C.-C.; Su W.-C.; Yen C.-J.; CHIH-HUNG HSU; Su W.-P.; Yeh K.-H.; Lu Y.-S.; Cheng A.-L.; Huang D.C.-L.; Fritsch H.; Voss F.; Taube T.; Yang J.C.-H. |
| 臺大學術典藏 |
2020-04-28T07:25:09Z |
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours
|
Cheng A.-L.; Twelves C.; Bogenrieder T.; Huang D.C.-L.; Strelkowa N.; Yen C.-J.; Anthoney A.; Jove M.; Buschke S.; Fuertig R.; Schmid U.; Goeldner R.-G.; Shiah H.-S.; Yang J.C.-H.; CHIH-HUNG HSU; Lee J.-H.; de Bono J.; Lin C.-C.; Chen L.-T.; Corral J.; Michalarea V.; Rihawi K.; Ong M.; De Bono J.;Lin C.-C.;Chen L.-T.;Corral J.;Michalarea V.;Rihawi K.;Ong M.;Lee J.-H.;Chih-Hung Hsu;Yang J.C.-H.;Shiah H.-S.;Yen C.-J.;Anthoney A.;Jove M.;Buschke S.;Fuertig R.;Schmid U.;Goeldner R.-G.;Strelkowa N.;Huang D.C.-L.;Bogenrieder T.;Twelves C.;Cheng A.-L. |
| 臺大學術典藏 |
2020-04-10T12:51:10Z |
Phase ii multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancer
|
Su W.-C.; Chao Y.; Yeh K.-H.; Cheng A.-L.; Chen L.-T.; Lin Z.-Z.; Shen Y.-C.; Li C.-P.; Yen C.-J.; Chiun Hsu; Lin Y.-L.; Shen Y.-C.;Li C.-P.;Yen C.-J.;Chiun Hsu;Lin Y.-L.;Lin Z.-Z.;Chen L.-T.;Su W.-C.;Chao Y.;Yeh K.-H.;Cheng A.-L. |
| 臺大學術典藏 |
2020-04-10T12:51:06Z |
A phase II study of the efficacy and safety of the combination therapy of the MEK inhibitor refametinib (BAY 86-9766) plus sorafenib for Asian patients with unresectable hepatocellular carcinoma
|
Lim H.Y.; Heo J.; Choi H.J.; Lin C.-Y.; Yoon J.-H.; Chiun Hsu; Rau K.-M.; Poon R.T.P.; Yeo W.; Park J.-W.; Tay M.H.; Hsieh W.-S.; Kappeler C.; Rajagopalan P.; Krissel H.; Jeffers M.; Yen C.-J.; Tak W.Y. |
| 臺大學術典藏 |
2020-04-10T12:15:59Z |
Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)
|
Chen Y.-C.; Ohishi N.; O’Neil B.; Schwartz L.; Smith-Jones P.M.; Ohtomo T.; Tanaka T.; Morikawa H.; Maki Y.; Frenette C.; Lin Z.-Z.; YU-YUN SHAO; Wan P.; Ma J.; Lyashchenko S.K.; Gansukh B.; Pandit-Taskar N.; Ruan S.; Beylergil V.; O’Donoghue J.; Abou-Alfa G.K.;Yen C.-J.;Hsu C.-H.;O’Donoghue J.;Beylergil V.;Ruan S.;Pandit-Taskar N.;Gansukh B.;Lyashchenko S.K.;Ma J.;Wan P.;Yu-Yun Shao;Lin Z.-Z.;Frenette C.;O’Neil B.;Schwartz L.;Smith-Jones P.M.;Ohtomo T.;Tanaka T.;Morikawa H.;Maki Y.;Ohishi N.;Chen Y.-C.;Agajanov T.;Boisserie F.;Di Laurenzio L.;Lee R.;Larson S.M.;Cheng A.-L.;Carrasquilo J.A.; Abou-Alfa G.K.; Yen C.-J.; Hsu C.-H.; Agajanov T.; Boisserie F.; Di Laurenzio L.; Lee R.; Larson S.M.; Cheng A.-L.; Carrasquilo J.A. |
| 臺大學術典藏 |
2020-04-10T12:15:58Z |
Impact of Undertreatment of Cancer Pain With Analgesic Drugs on Patient Outcomes: A Nationwide Survey of Outpatient Cancer Patient Care in Taiwan
|
Shen W.-C.;Chen J.-S.;Yu-Yun Shao;Lee K.-D.;Chiou T.-J.;Sung Y.-C.;Rau K.-M.;Yen C.-J.;Liao Y.-M.;Liu T.-C.;Wu M.-F.;Lee M.-Y.;Yu M.-S.;Hwang W.-L.;Lai P.-Y.;Chang C.-S.;Chou W.-C.;Hsieh R.-K.; Shen W.-C.; Chen J.-S.; YU-YUN SHAO; Lee K.-D.; Chiou T.-J.; Sung Y.-C.; Rau K.-M.; Yen C.-J.; Liao Y.-M.; Liu T.-C.; Wu M.-F.; Lee M.-Y.; Yu M.-S.; Hwang W.-L.; Lai P.-Y.; Chang C.-S.; Chou W.-C.; Hsieh R.-K. |
| 臺大學術典藏 |
2020-04-10T12:15:55Z |
A nationwide survey of adherence to analgesic drugs among cancer patients in Taiwan: prevalence, determinants, and impact on quality of life
|
Chou W.-C.;Chen J.-S.;Hung C.-Y.;Lu C.-H.;Yu-Yun Shao;Chiou T.-J.;Sung Y.-C.;Rau K.-M.;Yen C.-J.;Yeh S.-P.;Liu T.-C.;Wu M.-F.;Lee M.-Y.;Yu M.-S.;Hwang W.-L.;Lai P.-Y.;Chang C.-S.;Hsieh R.-K.; Chou W.-C.; Chen J.-S.; Hung C.-Y.; Lu C.-H.; YU-YUN SHAO; Chiou T.-J.; Sung Y.-C.; Rau K.-M.; Yen C.-J.; Yeh S.-P.; Liu T.-C.; Wu M.-F.; Lee M.-Y.; Yu M.-S.; Hwang W.-L.; Lai P.-Y.; Chang C.-S.; Hsieh R.-K. |
| 臺大學術典藏 |
2020-04-10T12:15:55Z |
Patients with head and neck cancer may need more intensive pain management to maintain daily functioning: a multi-center study
|
Hwang W.-L.; Liu T.-C.; Yu M.-S.; Sung Y.-C.; Lee K.-D.; Lai P.-Y.; Hsieh R.-K.; Lee M.-Y.; Chiou T.-J.; Yeh S.-P.; Chen J.-S.; Chang C.-S.; Cho S.-F.;Rau K.-M.;Yu-Yun Shao;Yen C.-J.;Wu M.-F.;Chen J.-S.;Chang C.-S.;Yeh S.-P.;Chiou T.-J.;Hsieh R.-K.;Lee M.-Y.;Sung Y.-C.;Lee K.-D.;Lai P.-Y.;Yu M.-S.;Hwang W.-L.;Liu T.-C.; Cho S.-F.; Rau K.-M.; YU-YUN SHAO; Yen C.-J.; Wu M.-F. |
| 臺大學術典藏 |
2020-04-10T12:15:54Z |
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
|
Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; Hsu C.-H.; Cheng A.-L.; Yen C.-J.; Chao Y.; Lu L.-C.; Hsu C.; YU-YUN SHAO; Lu L.-C.;Hsu C.;Yu-Yun Shao;Chao Y.;Yen C.-J.;Shih I.-L.;Hung Y.-P.;Chang C.-J.;Shen Y.-C.;Guo J.-C.;Liu T.-H.;Hsu C.-H.;Cheng A.-L. |
| 臺大學術典藏 |
2020-04-10T12:15:52Z |
Satisfaction with pain management and impact of pain on quality of life in cancer patients
|
Hwang W.-L.; Chiou T.-J.; Lai P.-Y.; Yen C.-J.; Lin J.; Hsieh R.-K.; Chen J.-S.; Lee K.-D.; Rau K.-M.; YU-YUN SHAO; Sung Y.-C.; Yeh S.-P.; Chang C.-S.; Liu T.-C.; Wu M.-F.; Lee M.-Y.; Yu M.-S. |
| 臺大學術典藏 |
2020-03-27T02:03:30Z |
High peritoneal KT/V and peritonitis rates are associated with peritoneal calcification.
|
Lee J.K.; Wu H.Y.; Chiang C.K.; Cheng H.T.; Yen C.J.; Hung K.Y.; Wu C.K.; Fang C.C.; KAO-LANG LIU; Yang C.Y.; Lien Y.C.; Huang J.W.; Huang J.W.;Lien Y.C.;Yang C.Y.;Kao-Lang Liu;Fang C.C.;Wu C.K.;Lee J.K.;Wu H.Y.;Chiang C.K.;Cheng H.T.;Yen C.J.;Hung K.Y. |
| 臺大學術典藏 |
2020-03-27T02:03:28Z |
Osteoprotegerin, inflammation and dyslipidemia are associated with abdominal aortic calcification in non-diabetic patients on peritoneal dialysis
|
Hung K.-Y.; Huang J.-W.;Lien Y.-C.;Yang C.-Y.;Kao-Lang Liu;Wu C.-F.;Yen C.-J.;Wu C.-K.;Lee J.-K.;Ho S.-R.;Wu H.-Y.;Chiang C.-K.;Cheng H.-T.;Shyu R.-S.;Hung K.-Y.; Huang J.-W.; Lien Y.-C.; Yang C.-Y.; KAO-LANG LIU; Wu C.-F.; Yen C.-J.; Wu C.-K.; Lee J.-K.; Ho S.-R.; Wu H.-Y.; Chiang C.-K.; Cheng H.-T.; Shyu R.-S. |
| 臺大學術典藏 |
2020-03-24T07:38:18Z |
Effect of intraperitoneally administered agents on human peritoneal mesothelial cell growth
|
Tsai T.-J.;Yen C.-J.;Cheng-Chung Fang;Yang C.-C.;Lee P.-H.;Yen T.-S.; Yen T.-S.; Yang C.-C.; Lee P.-H.; CHENG-CHUNG FANG; Tsai T.-J.; Yen C.-J. |
| 臺大學術典藏 |
2020-03-24T07:38:17Z |
Extracellular matrix proteins modulate human peritoneal mesothelial cell behavior
|
Tsai T.-J.; Lee P.-H.; Wu K.-D.; Yen C.-J.;Cheng-Chung Fang;Chen Y.-M.;Lin R.-H.;Wu K.-D.;Lee P.-H.;Tsai T.-J.; Yen C.-J.; CHENG-CHUNG FANG; Chen Y.-M.; Lin R.-H. |
| 臺大學術典藏 |
2020-03-24T07:38:17Z |
Hydralazine inhibits human peritoneal mesothelial cell proliferation and collagen synthesis
|
CHENG-CHUNG FANG; Yen C.-J.; Chen Y.-M.; Ko F.-N.; Tsai T.-J.; Lee P.-H.; Hsieh B.-S.; Cheng-Chung Fang;Yen C.-J.;Chen Y.-M.;Ko F.-N.;Tsai T.-J.;Lee P.-H.;Hsieh B.-S. |
| 臺大學術典藏 |
2020-03-24T07:38:17Z |
Effects of Intraperitoneal Antibiotics on Human Peritoneal Mesothelial Cell Growth
|
Yen T.-S.; Tsai K.-S.; Hung K.-Y.; Lee P.-H.; Lin R.-H.; Yang C.-C.; CHENG-CHUNG FANG; Chen H.-S.; Tsai T.-J.; Yen C.-J.; Yen C.-J.;Tsai T.-J.;Chen H.-S.;Cheng-Chung Fang;Yang C.-C.;Lee P.-H.;Lin R.-H.;Tsai K.-S.;Hung K.-Y.;Yen T.-S. |
| 臺大學術典藏 |
2020-03-24T07:38:16Z |
Pentoxifylline inhibits human peritoneal mesothelial cell growth and collagen synthesis: Effects on TGF-�]
|
Cheng-Chung Fang;Yen C.-J.;Chen Y.-M.;Shyu R.-S.;Tsai T.-J.;Lee P.-H.;Hsieh B.-S.; CHENG-CHUNG FANG; Yen C.-J.; Chen Y.-M.; Shyu R.-S.; Tsai T.-J.; Lee P.-H.; Hsieh B.-S. |
| 臺大學術典藏 |
2020-03-24T07:38:06Z |
Diltiazem suppresses collagen synthesis and IL-1�]-induced TGF-�]1 production on human peritoneal mesothelial cells
|
Tsai T.-J.;Yang J.-Y.;Lin M.-T.;Chu T.-S.;Chen Y.-M.;Yen C.-J.;CHENG-CHUNG FANG; CHENG-CHUNG FANG; Yen C.-J.; Chen Y.-M.; Chu T.-S.; Lin M.-T.; Yang J.-Y.; Tsai T.-J. |
| 臺大學術典藏 |
2020-03-24T07:38:00Z |
Fibrin-Induced Epithelial-to-Mesenchymal Transition of Peritoneal Mesothelial Cells as a Mechanism of Peritoneal Fibrosis: Effects of Pentoxifylline
|
Cheng-Chung Fang;Huang J.-W.;Shyu R.-S.;Yen C.-J.;Shiao C.-H.;Chiang C.-K.;Hu R.-H.;Tsai T.-J.; CHENG-CHUNG FANG; Huang J.-W.; Shyu R.-S.; Yen C.-J.; Shiao C.-H.; Chiang C.-K.; Hu R.-H.; Tsai T.-J. |
| 臺大學術典藏 |
2020-03-24T07:37:59Z |
Peritoneal dialysis peritonitis by anaerobic pathogens: A retrospective case series
|
Chao C.-T.; Lee S.-Y.; Yang W.-S.; Chen H.-W.; CHENG-CHUNG FANG; Yen C.-J.; Chiang C.-K.; Hung K.-Y.; Huang J.-W. |
| 臺大學術典藏 |
2020-03-24T07:37:57Z |
Sequence variants of peroxisome proliferator-activated receptor-gamma gene and the clinical courses of patients with end-stage renal disease
|
Chao C.-T.; Chen Y.-C.; Chiang C.-K.; Huang J.-W.; Hu F.-C.; CHENG-CHUNG FANG; Chang C.-C.; Yen C.-J. |
| 臺大學術典藏 |
2020-03-24T07:37:57Z |
Acinetobacter peritoneal dialysis peritonitis: A changing landscape over time
|
Huang J.-W.; Hung K.-Y.; Chiang C.-K.; Yen C.-J.; Chao C.-T.; Lee S.-Y.; Yang W.-S.; Chen H.-W.; CHENG-CHUNG FANG |
| 臺大學術典藏 |
2020-03-24T07:37:55Z |
Diabetes mellitus, superoxide dismutase and peroxisome proliferator activated receptor gamma polymorphisms modify the outcome of end-stage renal disease patients of Han Chinese origin
|
Yen C.-J.; Chang C.-C.; Hu F.-C.; CHENG-CHUNG FANG; Chen Y.-C.; Chiang C.-K.; Huang J.-W.; Chao C.-T. |
| 臺大學術典藏 |
2020-03-23T04:01:07Z |
Diltiazem suppresses collagen synthesis and IL-1β-induced TGF-β1 production on human peritoneal mesothelial cells
|
Fang C.-C.;Yen C.-J.;Chen Y.-M.;Chu T.-S.;Ming-Tsan Lin;Yang J.-Y.;Tsai T.-J.; Fang C.-C.; Yen C.-J.; Chen Y.-M.; Chu T.-S.; MING-TSAN LIN; Yang J.-Y.; Tsai T.-J. |
| 臺大學術典藏 |
2020-03-05T05:37:47Z |
Effect of Kidney Dysfunction on Cerebral Cortical Thinning in Elderly Population
|
Chen C.-H.; Chen Y.-F.; Chiu M.-J.; Chen T.-F.; Tsai P.-H.; Chen J.-H.; Yen C.-J.; Tang S.-C.; SHIN-JOE YEH; Chen Y.-C. |
| 臺大學術典藏 |
2020-03-04T05:42:41Z |
Effect of Kidney Dysfunction on Cerebral Cortical Thinning in Elderly Population
|
Chen C.-H; Chen Y.-F; Chiu M.-J; Chen T.-F; Tsai P.-H; Chen J.-H; Yen C.-J; SUNG-CHUN TANG; Yeh S.-J; Chen Y.-C. |
| 臺大學術典藏 |
2020-03-04T05:34:53Z |
Effect of Kidney Dysfunction on Cerebral Cortical Thinning in Elderly Population
|
Chen C.-H.; Chen Y.-F.; MING-JANG CHIU; Chen T.-F.; Tsai P.-H.; Chen J.-H.; Yen C.-J.; Tang S.-C.; Yeh S.-J.; Chen Y.-C. |
| 臺大學術典藏 |
2020-03-03T01:14:40Z |
Effect of Kidney Dysfunction on Cerebral Cortical Thinning in Elderly Population
|
Chen C.-H; Chen Y.-F; Chiu M.-J; TA-FU CHEN; Tsai P.-H; Chen J.-H; Yen C.-J; Tang S.-C; Yeh S.-J; Chen Y.-C. |
| 臺大學術典藏 |
2020-03-02T12:10:52Z |
Effect of Kidney Dysfunction on Cerebral Cortical Thinning in Elderly Population
|
Chen C.-H; Chen Y.-F; Chiu M.-J; Chen T.-F; Tsai P.-H; Chen J.-H; Yen C.-J; SUNG-CHUN TANG; Yeh S.-J; Chen Y.-C. |
| 臺大學術典藏 |
2020-03-02T03:10:58Z |
Genome-wide association study for autism spectrum disorder in taiwanese han population
|
Kuo P.-H.; Chuang L.-C.; Su M.-H.; Chen C.-H.; Wu J.-Y.; Yen C.-J.; Wu Y.-Y.; Liu S.-K.; Chou M.-C.; Chou W.-J.; Chiu Y.-N.; Tsai W.-C.; SUSAN SHUR-FEN GAU; Esteban F.J. |
| 臺大學術典藏 |
2020-02-27T07:43:40Z |
Seasonal effects on cardiovascular mortality in older patients [6]
|
Yen C.-J.; Lee Y.-T.;Liau C.-S.;WEN-JONE CHEN;Sung F.-C.;Chao C.-L.;Yen C.-J.; Chao C.-L.; Sung F.-C.; WEN-JONE CHEN; Liau C.-S.; Lee Y.-T. |
| 臺大學術典藏 |
2020-02-20T06:53:14Z |
Modified hospital elder life program: Effects on abdominal surgery patients
|
Chen C.C.-H.;Lin M.-T.;Yu-Wen Tien;Yen C.-J.;Huang G.-H.;Inouye S.K.; Chen C.C.-H.; Lin M.-T.; YU-WEN TIEN; Yen C.-J.; Huang G.-H.; Inouye S.K. |
| 臺大學術典藏 |
2020-02-20T02:56:54Z |
Angiopoietin-like protein 1 antagonizes MET receptor activity to repress sorafenib resistance and cancer stemness in hepatocellular carcinoma
|
Chen H.-A.; Kuo T.-C.; Tseng C.-F.; Ma J.-T.; Yang S.-T.; Yen C.-J.; CHING-YAO YANG; Sung S.-Y.; Su J.-L. |
| 臺大學術典藏 |
2020 |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
|
Douillard J.-Y.; Yoshino T.; CHIH-HUNG HSU; Yen Y.; Tabernero J.; Shen Y.-C.; Hsu C.; Ren Z.; Malhotra H.; Ueno M.; Ryoo B.-Y.; Kiang T.C.; Tai D.; Vogel A.; Cervantes A.; Lu S.-N.; Yen C.-J.; Huang Y.-H.; Chen S.-C.; Cheng A.-L.; Martinelli E.; Chen L.-T.; Chen L.-T.;Martinelli E.;Cheng A.-L.;Pentheroudakis G.;Qin S.;Bhattacharyya G.S.;Ikeda M.;Lim H.-Y.;Ho G.F.;Choo S.P.;Ren Z.;Malhotra H.;Ueno M.;Ryoo B.-Y.;Kiang T.C.;Tai D.;Vogel A.;Cervantes A.;Lu S.-N.;Yen C.-J.;Huang Y.-H.;Chen S.-C.;Hsu C.;Shen Y.-C.;Tabernero J.;Yen Y.;Chih-Hung Hsu;Yoshino T.;Douillard J.-Y.; Choo S.P.; Ho G.F.; Lim H.-Y.; Ikeda M.; Bhattacharyya G.S.; Qin S.; Pentheroudakis G. |
| 臺大學術典藏 |
2020 |
Immediate knowledge improvement and long-term teaching confidence after general medicine faculty training program
|
Yen C.-J.; Sheng W.-H.; Tsai S.-L.; Chu T.-S.; Ko B.-S.; Lin L.-C.; Tseng F.-Y.; Chang C.-H.; Wu C.-H.; Shih S.-R.; Chiu W.-Y.; Pan S.-C.; Chen W.-P.; PO-YUAN CHANG |
| 臺大學術典藏 |
2020 |
Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study
|
Su Y.-Y.; Chen J.-S.; Shan Y.-S.; Chen L.-T.; Tsou H.-H.; CHIUN HSU; Yen C.-J.; Yang S.-H.; Chen M.-H.; Chiang N.-J. |
| 國立成功大學 |
2020 |
Validation of genome-wide association study-identified single nucleotide polymorphisms in a case-control study of pancreatic cancer from Taiwan
|
Shan, Y.-S.;Chen, L.-T.;Wu, J.-S.;Chang, Y.-F.;Lee, C.-T.;Wu, C.-H.;Chiang, N.-J.;Huang, Huang H.-E.;Yen, C.-J.;Chao, Y.-J.;Tsai, H.-J.;Chen, Chen C.-Y.;Kang, J.-W.;Kuo, C.-F.;Tsai, C.-R.;Weng, Y.-L.;Yang, H.-C.;Liu, H.-C.;Chang, J.S. |
| 國立成功大學 |
2020 |
Two-year follow-up of a randomized phase III clinical trial of nivolumab vs. the investigator's choice of therapy in the Asian population for recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141)
|
Yen, C.-J.;Kiyota, N.;Hanai, N.;Takahashi, S.;Yokota, T.;Iwae, S.;Shimizu, Y.;Hong, R.-L.;Goto, M.;Kang, J.-H.;Li, W.S.K.;Ferris, R.L.;Gillison, M.;Endo, T.;Jayaprakash, V.;Tahara, M. |
| 國立成功大學 |
2020 |
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours
|
de, Bono J.;Lin, C.-C.;Chen, L.-T.;Corral, J.;Michalarea, V.;Rihawi, K.;Ong, M.;Lee, J.-H.;Hsu, C.-H.;Yang, J.C.-H.;Shiah, H.-S.;Yen, C.-J.;Anthoney, Anthoney A.;Jove, M.;Buschke, S.;Fuertig, R.;Schmid, U.;Goeldner, R.-G.;Strelkowa, N.;Huang, D.C.-L.;Bogenrieder, T.;Twelves, C.;Cheng, A.-L. |
| 國立成功大學 |
2020 |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
|
Chen, L.-T.;Martinelli, E.;Cheng, A.-L.;Pentheroudakis, G.;Qin, S.;Bhattacharyya, G.S.;Ikeda, M.;Lim, H.-Y.;Ho, G.F.;Choo, S.P.;Ren, Z.;Malhotra, H.;Ueno, M.;Ryoo, B.-Y.;Kiang, T.C.;Tai, D.;Vogel, A.;Cervantes, A.;Lu, S.-N.;Yen, C.-J.;Huang, Y.-H.;Chen, S.-C.;Hsu, C.;Shen, Y.-C.;Tabernero, J.;Yen, Yen Y.;Hsu, C.-H.;Yoshino, T.;Douillard, J.-Y. |
